Ctbp2 associated_with HCC
Evidence from:
primary |
all sources
Evidence (6 sources)
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
CtBP2 might be involved in EMT in HCC.
confidence: 0.85
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
CtBP2 bound SNAI1 ... promoted GLI1/SNAI1 driven EMT in HCC.
confidence: 0.85
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
CtBP2 expression accelerated HCC cell mobility and invasiveness
confidence: 0.70
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
mechanism underlying CtBP2 promotion of HCC progression
confidence: 0.70
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
To verify the role of CtBP2 on EMT in HCC
confidence: 0.90
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
(2015)
PMID:25686837
cited
relationship between CtBP2, SNAI1 and EMT in HCC
confidence: 0.70